524703 — Sandu Pharmaceuticals Balance Sheet
0.000.00%
- IN₹386.54m
- IN₹353.81m
- IN₹671.92m
- 93
- 46
- 27
- 59
Annual balance sheet for Sandu Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 117 | 41.7 | 23 | 12.1 | 26.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 53.5 | 39.9 | 47.9 | 48.7 | 47.6 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 305 | 236 | 255 | 223 | 263 |
| Net Property, Plant And Equipment | 161 | 164 | 170 | 178 | 181 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 470 | 493 | 542 | 524 | 557 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 125 | 119 | 139 | 106 | 121 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 135 | 128 | 149 | 118 | 137 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 335 | 365 | 392 | 406 | 420 |
| Total Liabilities & Shareholders' Equity | 470 | 493 | 542 | 524 | 557 |
| Total Common Shares Outstanding |